Placebo response in environmental disease: Chelation therapy of patients with symptoms attributed to amalgam fillings

Journal of Occupational and Environmental Medicine

Volumn 39, Issue 8, 1997, Pages 707-714

  Grandjean, Philippe ^a   Guldager, Bernadette ^a   Larsen, Inge Birk ^b   Jørgensen, Poul J ^c   Holmstrup, Palle ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMALGAM; LEAD; MERCURY; PLACEBO; SUCCIMER;

ADULT; AGED; ANXIETY; ARTICLE; CHELATION THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; ENVIRONMENTAL DISEASE; EXTRAVERSION; FEMALE; HUMAN; LEAD POISONING; MALE; MERCURIALISM; OBSESSION; ORAL DRUG ADMINISTRATION; PERSONALITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOMATIZATION; TOOTH FILLING; URINARY EXCRETION;

ADULT; AGED; CHELATING AGENTS; DENMARK; DENTAL AMALGAM; DOUBLE-BLIND METHOD; ENVIRONMENTAL ILLNESS; FEMALE; HUMANS; LEAD; MALE; MERCURY; MIDDLE AGED; PLACEBO EFFECT; SUCCIMER;

EID: 0030746713     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-199708000-00004     Document Type: Article

References (41)

1. Black DW, Rathe A, Goldstein RB. Environmental illness: a controlled study of 26 patients with '20th century disease.' JAMA. 1990;264:3166-3170.
2. Ashford N, Heinzow B, Lütjen K, et al. Chemical Sensitivity in Selected European Countries: An Exploratory Study. Athens: Ergonomia; 1995.
3. Sparks PJ, Daniell W, Black DW, et al. Multiple chemical sensitivity syndrome: a clinical perspective. II. Evaluation, diagnostic testing, treatment, and social considerations. J Occup Med. 1994;36:731-737.
4. Subcommittee on Risk Management. Dental Amalgam: A Scientific Review and Recommended Public Health Service Strategy for Research, Education and Regulation. Washington, DC: Department of Health and Human Services; 1993.
5. Clarkson TW, Friberg L, Hursh JB, Nylander M. The prediction of intake of mercury vapor from amalgams. In: Clarkson TW, Friberg L, Nordberg GF, Sager PR, eds. Biological Monitoring of Toxic Metals. New York: Plenum; 1988: 247-264.
6. Halbach S. Estimation of mercury dose by a novel quantitation of elemental and inorganic species released from amalgam. Int Arch Occup Environ Health. 1995;67:295-300.
7. Weiner JA, Nylander M, Berglund F. Does mercury from amalgam restorations constitute a health hazard? Sci Total Environ. 1990;99:1-22.
8. Mackert JR Jr. Dental amalgam and mercury. J Am Dent Assoc. 1991;122:54-61.
9. Lindberg NE, Lindberg E, Larsson G. Psychologic factors in the etiology of amalgam illness. Acta Odontol Scand. 1994;52:219-228.
10. Smith RG, Vorwald AJ, Patil LS, Mooney TF. Effect of exposure to mercury in the manufacture of chlorine. Am Ind Hyg Assoc J. 1970;31:687-700.
11. International Programme on Chemical Safety. Inorganic Mercury (Environmental Health Criteria 118). Geneva: World Health Organization; 1991.
12. Grandjean P. Health significance of metals. In: Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health & Preventive Medicine, 13th ed. Norwalk, CT: Appleton & Lange; 1991:381-401.
13. Siblerud RL, Motl J, Kienholz E. Psychometric evidence that mercury from silver dental fillings may be an etiological factor in depression, excessive anger, and anxiety. Psychol Rep. 1994;74:67-80.
14. Klock B, Blomgren J, Ripa U, Andrup B. Effect of amalgam removal in patients who suspect that they suffer from or have suffered from amalgam poisoning [in Swedish]. Tandläkartidn. 1989;81:1297-1302.
15. Ahlqwist M, Bengtsson C, Furunes B, Hollender L, Lapidus L. Number of amalgam tooth fillings in relation to subjectively experienced symptoms in a study of Swedish women. Community Dent Oral Epidemiol. 1988;16:227-231.
16. Lichtenberg H. Elimination of symptoms by removal of dental amalgam from mercury poisoned patients, as compared with a control group of average patients. J Orthomol Med. 1993;8:145-148.
17. Ding G-S, Liang Y-Y. Antidotal effects of dimercaptosuccinic acid. J Appl Toxicol. 1991;11:7-14.
18. Englund GS, Dahlqvist R, Lindelöf B, et al. DMSA administration to patients with alleged mercury poisoning from dental amalgams: a placebo-controlled study. J Dent Res. 1994;73:620-628.
19. Grandjean P, Jacobsen IA, Jørgensen PJ. Chronic lead poisoning treated with DMSA. Pharmacol Toxicol. 1991;68:266-269.
20. Eysenck HJ, Eysenck SGB. The Manual of the Eysenck Personality Questionnaire. London: Hodder & Stoughton; 1975.
21. Derogatis LR, Cleary PA. Confirmation of the dimensional structure of the SCL-90: a study in construct validation. J Clin Psychol. 1977;33:981-989.
22. Bech P, Jørgensen B, Jeppesen K, Loldrup Poulsen D, Vanggard T. Personality in depression: concordance between clinical assessment and questionnaires. Acta Psychiatr Scand. 1986;74:263-268.
23. Mortensen EL, Reinisch JM, Sanders SA. Psychometric properties of the Danish 16PF and EPQ. Scand J Psychol. 1996;37:221-225.
24. Guldager B, Jørgensen PJ, Grandjean P. Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA. Clin Chem. 1996;42:1938-1942.
25. Andersen HR, Nielsen JB, Nielsen F, Grandjean P. Antioxidative enzyme activities in human erythrocytes. Clin Chem. 1997:43:562-568.
26. Bluhm R, Bobbitt RG, Welch LW, et al. Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali workers. Part I: History, neuropsychological findings and chelator effects. Hum Exp Toxicol. 1992;11:201-210.
27. Shapiro IM, Cornblath DR, Sumner AJ, et al. Neurophysiological and neuropsychological function in mercury-exposed dentists. Lancet. 1982;1:1147-1150.
28. Uzzell BP, Oler J. Chronic low-level mercury exposure and neuropsychological functioning. J Clin Exp Neuropsychol. 1986;8:581-593.
29. Köppel C. Mercury concentrations, clinical and neuropsychological findings in patients suspecting mercury poisoning from amalgam fillings. In: Friberg LT, Schrauzer GN, eds. Status Quo and Perspectives of Amalgam and Other Dental Materials. Stuttgart: Georg Thieme; 1995:70-74.
30. Handley J, Todd D, Burrows D. Mercury allergy in a contact dermatitis clinic in Northern Ireland. Contact Derm. 1993; 29:258-261.
31. Green BL, Lindy JD, Grace MC. Psychological effects of toxic contamination. In: Ursano RJ, McCaughey BG, Fullerton CS, eds. Individual and Community Responses to Trauma and Disaster. Cambridge: Cambridge University Press: 1994:154-176.
32. Stewart DE. The changing faces of somatization. Psychosomatics. 1990;31:153-158.
33. Jokstad A, Thomassen Y, Bye E, Clench-Aas J, Aaseth J. Dental amalgam and mercury. Pharmacol Toxicol. 1992;70:308-313.
34. Mortensen ME, Valenzuela PM. 2,3-Dimercaptosuccinic acid (DMSA) chelation in mercury (Hg) vapor poisoning [abstract]. Vet Hum Toxicol. 1990;32:362.
35. Houeto P, Sandouk P, Baud FJ, Levillain P. Elemental mercury vapour toxicity: treatment and levels in plasma and urine. Hum Exp Toxicol. 1994;13:848-852.
36. Honigfeld G. Non-specific factors in treatment. I. Review of placebo reactions and placebo reactors. Dis Nerv Syst. 1964;25:146-156.
37. Gowdey CW. A guide to the pharmacology of placebo. Can Med Assoc J. 1983;128:921-924.
38. Shapiro AK, Struening EL, Shapiro E. The reliability and validity of a placebo test. J Psychiatr Res. 1980;15:253-290.
39. Andersson B, Berg M, Arnetz BB Melin L, Langlet I, Lidén S. A cognitive-behavioral treatment of patients suffering from "electric hypersensitivity." J Occup Environ Med. 1996;38:752-758.
40. Council on Scientific Affairs, American Medical Association. Clinical Ecology. JAMA. 1992;268:3465-3467.
41. Arnetz BB, Berg M, Anderzén I, Lundeberg T, Haker E. A noncenventional approach to the treatment of 'environmental illness.' J Occup Environ Med. 1995;37:838-844.